For K2P2.1cryst ML336 crystals, ML336 was dissolved in 100% DMSO at a concentration of 500 mM, diluted 1:100 in SEC buffer to 5 mM concentration, and then mixed to dissolve the compound completely. 12 mg ml−1 K2P2.1cryst then mixed 1:1 with the ML336-SEC buffer solution to achieve a final concentration of 6 mg ml−1 and 2.5mM of K2P2.1cryst and ML336, respectively. This mixture was then incubated for 2h on ice prior to crystallization using hanging-drop vapor diffusion at 4 °C and mixture of 0.2 μl of protein and 0.1 μl of precipitant over 100 μl of reservoir containing 20–25% PEG400, 200 mM KCl, 100 mM HEPES pH 8.0, 1 mM CdCl2. Crystals appeared in 12 h and grew to full size (200–300 μM) in about a week. Crystals were cryoprotected with buffer D (200 mM KCl, 0.2% OGNG, 15 mM HTG, 0.02% CHS, 100 mM HEPES pH 8.0,1 mM CdCl2) with 5% step increase of PEG400 up to a final concentration of 38% and flash-frozen in liquid nitrogen.
TREK-1CG*:CAT335 crystals, TREK-1CG*:CAT335a crystals, and TREK-1CG*:ML335 crystals grew in the similar conditions as the TREK-1:ML336 complex, but CAT335 and CAT335a were dissolved in 100% DMSO at a concentration of 20 mM and ML335 was dissolved in 100% DMSO at a concentration of 500 mM. Each ligand was diluted in SEC buffer and mixed 1:1 volume ratio to TREK-1CG* previously concentrated to 10 mg ml−1 to achieve final ligand:protein molar ratios of 1.1:1 CAT335, 2:1 CAT335a, and 5:1 ML335. These mixtures were incubated for 2h on ice prior to crystallization using hanging-drop diffusion at 4 °C and a mixture of 0.2 μl of protein and 0.1 μl of precipitant over 100 μl of reservoir containing 20–25% PEG400, 200 mM KCl, 100 mM HEPES pH 7.0 or 7.5, and 1 mM CdCl2. Crystals appeared in 12 h and grew to full size (200–300 μM) in about a week. Crystals were cryoprotected with buffer D (200 mM KCl, 0.2% OGNG, 15 mM HTG, 0.02% CHS, 100 mM HEPES pH 7.0 or 7.5, and 1 mM CdCl2) with 5% step increase of PEG400 up to a final concentration of 38% and flash-frozen in liquid nitrogen.
Datasets for K2P2.1–ligand complexes were collected at 100 K using synchrotron radiation at APS GM/CAT beamline 23-IDB/B Chicago, Illinois using a wavelength of 0.9779 Å, processed with XDS75, scaled and merged with Aimless76. Final resolution cut-off was 2.9 Å (K2P2.1cryst:ML336) and 3.0 Å (K2P2.1CG*:CAT335, K2P2.1CG*:CAT335a, and K2P2.1CG*:ML335), using the CC1/2 criterion77,78. Structures were solved by molecular replacement using the K2P2.1cryst structure (PDB: 6CQ6) as search model. Several cycles of manual rebuilding, using COOT79 and refinement using REFMAC580 and PHENIX81 were carried out to improve the electron density map. Ramachandran restraints were employed during refinement. Model quality was assessed using Molprobity82.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.